CAR-T cell therapy is one of the most advanced and expensive cancer treatments, often costing hundreds of thousands of dollars in countries like the United States. In places like India, the price can be lower due to differences in healthcare infrastructure, regulatory costs, and local manufacturing, but it remains a significant financial commitment. Beyond the therapy itself, additional costs—such as hospitalization, supportive care, pre-treatment testing, and follow-up monitoring—can add substantially to the overall expense. Understanding these factors and discussing financial assistance options with your treatment center can help patients plan and access this life-saving therapy.